ARCHIVES

Tempero, Johnson To Lead ASCO

This article is from The Cancer Letter archive.

Vol. 29 No. 13 | March 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

June 27, 2014

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

Swedish Study Finds Long Term Hormonal Therapy May Increase Breast Cancer Risk

August 4, 1989

ASCO Updates Guideline On Follow-Up Management

October 27, 2006